American International Group, Inc. Viracta Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.87 - $5.0 $33,660 - $90,000	-18,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.23 - $4.76 $2,823 - $6,026	-1,266 Reduced 6.57%	18,000 $86,000
Q4 2021 Feb 11, 2022	SELL	$3.37 - $7.91 $1,941 - $4,556	-576 Reduced 2.9%	19,266 $70,000
Q3 2021 Nov 12, 2021	SELL	$7.84 - $12.53 $3,700 - $5,914	-472 Reduced 2.32%	19,842 $159,000
Q2 2021 Aug 13, 2021	BUY	$7.55 - $12.95 $153,370 - $263,066	20,314 New	20,314 $230,000

3.66M

1.8K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $1.13M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.